Cargando…
G(s) protein peptidomimetics as allosteric modulators of the β(2)-adrenergic receptor
A series of G(s) protein peptidomimetics were designed and synthesised based on the published X-ray crystal structure of the active state β(2)-adrenergic receptor (β(2)AR) in complex with the G(s) protein (PDB 3SN6). We hypothesised that such peptidomimetics may function as allosteric modulators tha...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077236/ https://www.ncbi.nlm.nih.gov/pubmed/35542596 http://dx.doi.org/10.1039/c7ra11713b |
_version_ | 1784702077983784960 |
---|---|
author | Boyhus, Lotte-Emilie Danielsen, Mia Bengtson, Nina Smidt Ben Achim Kunze, Micha Kubiak, Xavier Sminia, Tjerk J. Løper, Jacob Hartvig Tran, Phuong Thu Lindorff-Larsen, Kresten Rasmussen, Søren G. F. Mathiesen, Jesper Mosolff Pedersen, Daniel Sejer |
author_facet | Boyhus, Lotte-Emilie Danielsen, Mia Bengtson, Nina Smidt Ben Achim Kunze, Micha Kubiak, Xavier Sminia, Tjerk J. Løper, Jacob Hartvig Tran, Phuong Thu Lindorff-Larsen, Kresten Rasmussen, Søren G. F. Mathiesen, Jesper Mosolff Pedersen, Daniel Sejer |
author_sort | Boyhus, Lotte-Emilie |
collection | PubMed |
description | A series of G(s) protein peptidomimetics were designed and synthesised based on the published X-ray crystal structure of the active state β(2)-adrenergic receptor (β(2)AR) in complex with the G(s) protein (PDB 3SN6). We hypothesised that such peptidomimetics may function as allosteric modulators that target the intracellular G(s) protein binding site of the β(2)AR. Peptidomimetics were designed to mimic the 15 residue C-terminal α-helix of the G(s) protein and were pre-organised in a helical conformation by (i, i + 4)-stapling using copper catalysed azide alkyne cycloaddition. Linear and stapled peptidomimetics were analysed by circular dichroism (CD) and characterised in a membrane-based cAMP accumulation assay and in a bimane fluorescence assay on purified β(2)AR. Several peptidomimetics inhibited agonist isoproterenol (ISO) induced cAMP formation by lowering the ISO maximal efficacy up to 61%. Moreover, some peptidomimetics were found to significantly decrease the potency of ISO up to 39-fold. In the bimane fluorescence assay none of the tested peptidomimetics could stabilise an active-like conformation of β(2)AR. Overall, the obtained pharmacological data suggest that some of the peptidomimetics may be able to compete with the native G(s) protein for the intracellular binding site to block ISO-induced cAMP formation, but are unable to stabilise an active-like receptor conformation. |
format | Online Article Text |
id | pubmed-9077236 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | The Royal Society of Chemistry |
record_format | MEDLINE/PubMed |
spelling | pubmed-90772362022-05-09 G(s) protein peptidomimetics as allosteric modulators of the β(2)-adrenergic receptor Boyhus, Lotte-Emilie Danielsen, Mia Bengtson, Nina Smidt Ben Achim Kunze, Micha Kubiak, Xavier Sminia, Tjerk J. Løper, Jacob Hartvig Tran, Phuong Thu Lindorff-Larsen, Kresten Rasmussen, Søren G. F. Mathiesen, Jesper Mosolff Pedersen, Daniel Sejer RSC Adv Chemistry A series of G(s) protein peptidomimetics were designed and synthesised based on the published X-ray crystal structure of the active state β(2)-adrenergic receptor (β(2)AR) in complex with the G(s) protein (PDB 3SN6). We hypothesised that such peptidomimetics may function as allosteric modulators that target the intracellular G(s) protein binding site of the β(2)AR. Peptidomimetics were designed to mimic the 15 residue C-terminal α-helix of the G(s) protein and were pre-organised in a helical conformation by (i, i + 4)-stapling using copper catalysed azide alkyne cycloaddition. Linear and stapled peptidomimetics were analysed by circular dichroism (CD) and characterised in a membrane-based cAMP accumulation assay and in a bimane fluorescence assay on purified β(2)AR. Several peptidomimetics inhibited agonist isoproterenol (ISO) induced cAMP formation by lowering the ISO maximal efficacy up to 61%. Moreover, some peptidomimetics were found to significantly decrease the potency of ISO up to 39-fold. In the bimane fluorescence assay none of the tested peptidomimetics could stabilise an active-like conformation of β(2)AR. Overall, the obtained pharmacological data suggest that some of the peptidomimetics may be able to compete with the native G(s) protein for the intracellular binding site to block ISO-induced cAMP formation, but are unable to stabilise an active-like receptor conformation. The Royal Society of Chemistry 2018-01-09 /pmc/articles/PMC9077236/ /pubmed/35542596 http://dx.doi.org/10.1039/c7ra11713b Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by/3.0/ |
spellingShingle | Chemistry Boyhus, Lotte-Emilie Danielsen, Mia Bengtson, Nina Smidt Ben Achim Kunze, Micha Kubiak, Xavier Sminia, Tjerk J. Løper, Jacob Hartvig Tran, Phuong Thu Lindorff-Larsen, Kresten Rasmussen, Søren G. F. Mathiesen, Jesper Mosolff Pedersen, Daniel Sejer G(s) protein peptidomimetics as allosteric modulators of the β(2)-adrenergic receptor |
title | G(s) protein peptidomimetics as allosteric modulators of the β(2)-adrenergic receptor |
title_full | G(s) protein peptidomimetics as allosteric modulators of the β(2)-adrenergic receptor |
title_fullStr | G(s) protein peptidomimetics as allosteric modulators of the β(2)-adrenergic receptor |
title_full_unstemmed | G(s) protein peptidomimetics as allosteric modulators of the β(2)-adrenergic receptor |
title_short | G(s) protein peptidomimetics as allosteric modulators of the β(2)-adrenergic receptor |
title_sort | g(s) protein peptidomimetics as allosteric modulators of the β(2)-adrenergic receptor |
topic | Chemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077236/ https://www.ncbi.nlm.nih.gov/pubmed/35542596 http://dx.doi.org/10.1039/c7ra11713b |
work_keys_str_mv | AT boyhuslotteemilie gsproteinpeptidomimeticsasallostericmodulatorsoftheb2adrenergicreceptor AT danielsenmia gsproteinpeptidomimeticsasallostericmodulatorsoftheb2adrenergicreceptor AT bengtsonninasmidt gsproteinpeptidomimeticsasallostericmodulatorsoftheb2adrenergicreceptor AT benachimkunzemicha gsproteinpeptidomimeticsasallostericmodulatorsoftheb2adrenergicreceptor AT kubiakxavier gsproteinpeptidomimeticsasallostericmodulatorsoftheb2adrenergicreceptor AT sminiatjerkj gsproteinpeptidomimeticsasallostericmodulatorsoftheb2adrenergicreceptor AT løperjacobhartvig gsproteinpeptidomimeticsasallostericmodulatorsoftheb2adrenergicreceptor AT tranphuongthu gsproteinpeptidomimeticsasallostericmodulatorsoftheb2adrenergicreceptor AT lindorfflarsenkresten gsproteinpeptidomimeticsasallostericmodulatorsoftheb2adrenergicreceptor AT rasmussensørengf gsproteinpeptidomimeticsasallostericmodulatorsoftheb2adrenergicreceptor AT mathiesenjespermosolff gsproteinpeptidomimeticsasallostericmodulatorsoftheb2adrenergicreceptor AT pedersendanielsejer gsproteinpeptidomimeticsasallostericmodulatorsoftheb2adrenergicreceptor |